Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
OMV AG

Start price
Target price
Perf. (%)
€38.01
03.10.22
€40.00
03.10.23
3.60%
18.10.22

Could be very worthwhile Investment >20% year
Fair valuation
Good rating
Standard Investments for future growth
buy
Tesla Inc

Start price
Target price
Perf. (%)
€281.67
29.07.22
-
25.08.25
-17.56%
18.10.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
buy
Tesla Inc

Start price
Target price
Perf. (%)
€281.67
29.07.22
-
25.08.25
-17.56%
18.10.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
Advicenne

Start price
Target price
Perf. (%)
€7.24
17.10.21
€6.00
17.10.22
-43.92%
18.10.22

Could be worthwhile Investment >10% per year
buy
Korian S.A.

Start price
Target price
Perf. (%)
€28.30
17.10.21
€30.00
17.10.22
-62.44%
18.10.22

Could be worthwhile Investment >10% per year
Durect Corp.

Start price
Target price
Perf. (%)
€1.03
17.10.21
-
17.10.22
-48.06%
18.10.22

Probably not worthwhile Investment
buy
Athersys Inc.

Start price
Target price
Perf. (%)
€1.87
19.09.22
€3.80
19.09.23
0.19%
17.10.22

Could be very worthwhile Investment >20% year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€8.64
19.09.22
€17.00
19.09.23
-34.41%
17.10.22

Could be very worthwhile Investment >20% year
buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.41
27.09.22
€11.60
27.09.23
8.69%
17.10.22

Could be very worthwhile Investment >20% year
buy
Volkswagen AG VZO

Start price
Target price
Perf. (%)
€129.66
30.09.22
€150.00
30.09.23
-0.26%
17.10.22

Could be worthwhile Investment >10% per year
buy
Porsche Automobil Holding SE

Start price
Target price
Perf. (%)
€61.02
30.09.22
€75.00
30.09.23
-4.03%
17.10.22

Could be worthwhile Investment >10% per year
buy
Shell plc

Start price
Target price
Perf. (%)
€25.70
01.10.22
€27.00
01.10.23
2.70%
17.10.22

EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
negative Cash Flow expected
buy
Shell plc

Start price
Target price
Perf. (%)
€25.70
01.10.22
€27.00
01.10.23
2.70%
17.10.22

EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
negative Cash Flow expected
buy
Shell plc

Start price
Target price
Perf. (%)
€25.70
01.10.22
€27.00
01.10.23
2.70%
17.10.22

EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
negative Cash Flow expected
Hypoport SE

Start price
Target price
Perf. (%)
€86.20
16.10.22
€90.00
16.10.23
-4.58%
17.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
buy
Mag Silver Corp.

Start price
Target price
Perf. (%)
€17.26
30.10.21
-
18.01.25
-25.35%
17.10.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€258.90
16.09.22
€350.00
16.10.22
-4.94%
17.10.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€9.36
16.10.21
€20.00
16.10.22
47.44%
17.10.22

Could be worthwhile Investment >10% per year
buy
Regulus Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.44
16.10.21
€8.00
16.10.22
-62.16%
17.10.22

Could be worthwhile Investment >10% per year
Freeport-McMoRan Inc.

Start price
Target price
Perf. (%)
€33.83
16.10.21
€30.00
16.10.22
-15.81%
17.10.22

Could be worthwhile Investment >10% per year
buy
Altamir Amboise

Start price
Target price
Perf. (%)
€23.86
16.10.21
€28.00
16.10.22
-1.78%
17.10.22

Could be worthwhile Investment >10% per year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.08
18.05.22
-
18.05.23
-3.43%
16.10.22

Risky Investment
buy
Hypoport SE

Start price
Target price
Perf. (%)
€88.85
11.10.22
€90.00
11.10.23
-2.98%
16.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.86
08.10.22
€5.00
08.10.23
9.28%
16.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Continental AG

Start price
Target price
Perf. (%)
€90.10
15.02.22
€130.00
15.02.24
-46.16%
16.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
positive Cash Flow expected